跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
莊 涵琄
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0001-8735-874X
電子郵件
151007
h.tmu.edu
tw
h-index
305
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2009
2023
每年研究成果
概覽
指紋
網路
研究成果
(13)
類似的個人檔案
(7)
指紋
查看啟用 Han-Chuan Chuang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
100%
Antibiotics
49%
Imipenem
48%
Antiinfective Agent
44%
Healthcare Associated Infection
37%
Observational Study
33%
Bloodstream Infection
33%
Aeromonas
33%
Carbapenem
33%
Immunogenicity
33%
Immune Reconstitution Inflammatory Syndrome
33%
Vaccination Policy
33%
Acinetobacter Baumannii
33%
Insulin Dependent Diabetes Mellitus
33%
HIV
33%
Levofloxacin
30%
Aminoglycoside
25%
Amikacin
20%
Ciprofloxacin
18%
Bacteremia
18%
Piperacillin Plus Tazobactam
18%
Pseudomonas Infection
17%
Infection
17%
Quinolone Derivative
16%
Infectious Agent
15%
Antibiotic Agent
15%
SARS Coronavirus
14%
Diabetic Ketoacidosis
13%
Graves Disease
13%
Antidiabetic Agent
13%
Cefepime
11%
Ceftazidime
11%
Gentamicin
11%
Meropenem
11%
Enterobacteriaceae
11%
D Dimer
9%
Beta Lactam Antibiotic
8%
Mortality Rate
8%
Lactam
8%
Critical Illness
8%
Antibiotic Therapy
8%
Liver Cirrhosis
7%
Malignant Neoplasm
7%
Carbapenem Derivative
7%
Antimicrobial Resistance
6%
Insulin Degludec
6%
Insulin Aspart
6%
Glutamate Decarboxylase
6%
Protein Tyrosine Phosphatase
6%
Non Insulin Dependent Diabetes Mellitus
6%
Medicine and Dentistry
COVID-19
77%
Computer Assisted Tomography
33%
Influenza A (H1N1)
33%
Pseudomonas aeruginosa
33%
Mixed Infection
33%
Monocyte
33%
Community-Acquired Pneumonia
33%
Tachypnea
33%
Diabetes Mellitus
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Reactogenicity
33%
Immunogenicity
33%
Pyogenic Liver Abscess
33%
Immune Reconstitution Inflammatory Syndrome
33%
Insulin Dependent Diabetes Mellitus
33%
Human Immunodeficiency Virus
33%
Antiretroviral Therapy
33%
Disease
30%
Platelet
22%
D-Dimer
22%
Infection
19%
Odds Ratio
19%
Fatality
11%
Injection Site Pain
11%
Cancer
11%
Liver Abscess
11%
Prognostic Factor
11%
Pathogen
11%
Body Weight
11%
Adverse Event
11%
Seroconversion
11%
Neutralizing Antibody
11%
Humoral Immunity
11%
Diabetes
9%
Emergency Department
9%
Coronavirinae
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Computed Tomography of Chest
8%
Diabetic Ketoacidosis
8%
Cell Count
8%
Graves' Disease
8%
Antidiabetic Agent
8%
Glycemic Control
8%
Neoplasm
5%
Physical Disease by Body Function
5%
Escherichia coli
5%
Antiinfective Agent
5%
Abscess
5%
Cephalosporin Derivative
5%
Prevalence
5%
Immunology and Microbiology
Abscess
66%
Klebsiella pneumoniae
37%
Human Immunodeficiency Virus
33%
Aeromonas veronii
33%
Aeromonas hydrophila
33%
Immune Reconstitution Inflammatory Syndrome
33%
Gastrointestinal Tract
33%
Diabetes Mellitus Type 1
33%
Immunogenicity
33%
Biovar
33%
Aeromonas caviae
33%
Vaccination Policy
33%
Plasmid
33%
Acinetobacter Baumannii
33%
Spike
19%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Minimum Inhibitory Concentration
14%
Glycemic Control
13%
Graves' Disease
13%
Glucose Blood Level
13%
CD4 Lymphocyte Count
13%
Serotype
11%
Platelet Count
9%
Vaccine Efficacy
9%
Infectious Agent
7%
Titer
6%
Thyroid Function
6%
Autoimmune Diabetes
6%
Cell Function
6%
